JP2007512027A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512027A5
JP2007512027A5 JP2006541617A JP2006541617A JP2007512027A5 JP 2007512027 A5 JP2007512027 A5 JP 2007512027A5 JP 2006541617 A JP2006541617 A JP 2006541617A JP 2006541617 A JP2006541617 A JP 2006541617A JP 2007512027 A5 JP2007512027 A5 JP 2007512027A5
Authority
JP
Japan
Prior art keywords
irna
irna molecule
cell
molecule
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541617A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512027A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039191 external-priority patent/WO2005081714A2/en
Publication of JP2007512027A publication Critical patent/JP2007512027A/ja
Publication of JP2007512027A5 publication Critical patent/JP2007512027A5/ja
Pending legal-status Critical Current

Links

JP2006541617A 2003-11-21 2004-11-22 トランスジェニック動物の産生における干渉ｒｎａの使用 Pending JP2007512027A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52393803P 2003-11-21 2003-11-21
PCT/US2004/039191 WO2005081714A2 (en) 2003-11-21 2004-11-22 Use of interfering rna in the production of transgenic animals

Publications (2)

Publication Number Publication Date
JP2007512027A JP2007512027A (ja) 2007-05-17
JP2007512027A5 true JP2007512027A5 (enExample) 2008-01-10

Family

ID=34910676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541617A Pending JP2007512027A (ja) 2003-11-21 2004-11-22 トランスジェニック動物の産生における干渉ｒｎａの使用

Country Status (7)

Country Link
US (1) US10793873B2 (enExample)
EP (2) EP2514826A3 (enExample)
JP (1) JP2007512027A (enExample)
CN (2) CN103397019A (enExample)
AU (1) AU2004316293A1 (enExample)
CA (1) CA2546853C (enExample)
WO (1) WO2005081714A2 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4948163B2 (ja) * 2003-05-23 2012-06-06 サーナ・セラピューティクス・インコーポレイテッド 化学修飾した低分子干渉核酸（ｓｉＮＡ）を使用する遺伝子発現のＲＮＡ干渉仲介抑制
CA2533259C (en) 2003-07-21 2014-01-28 Lifecell Corporation Acellular tissue matrices made from galactose .alpha.-1,3-galactose-deficient tissue
EP1582591A3 (en) * 2004-02-27 2005-12-21 Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut Sirna and their use for knock down expression of porcine endogenous retrovirus
DK1895835T3 (da) * 2005-06-24 2014-05-05 Recombinetics Inc Anvendelse af cytosindeaminaser til reducering af retroelementoverførsel fra grise til mennesker
JP2007104969A (ja) * 2005-10-13 2007-04-26 Bio Think Tank Co Ltd ショートヘアピン型ＲＮＡ（ｓｈＲＮＡ）前駆体を産生するための核酸及びその利用
CA2680589A1 (en) * 2007-03-14 2008-09-18 Universita' Degli Studi Di Milano - Bicocca Modulator compounds of the drug resistance in epithelial tumour cells
CA2691617C (en) 2007-05-31 2020-07-21 University Of Iowa Research Foundation Reduction of off-target rna interference toxicity
WO2008151364A1 (en) * 2007-06-13 2008-12-18 Commonwealth Scientific And Industrial Research Organisation Modulating production traits in avians
WO2010008562A2 (en) 2008-07-16 2010-01-21 Recombinetics Methods and materials for producing transgenic animals
EP2425015B1 (en) * 2009-04-29 2018-01-10 Ralph Wirtz A method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels
WO2011019929A1 (en) * 2009-08-14 2011-02-17 The Regents Of The University Of California Methods of diagnosing and treating autism
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
CA2802738A1 (en) * 2010-06-24 2011-12-29 The Ohio State University Chronic lymphocytic leukemia modeled in mouse by targeted mir-29 expression
EP2673286B1 (en) 2011-02-12 2019-07-03 University of Iowa Research Foundation Therapeutic compounds
CN102675438B (zh) * 2011-03-18 2015-04-22 中国科学院上海生命科学研究院 基于RNAi技术的抗虫制剂及方法
WO2013188358A1 (en) * 2012-06-12 2013-12-19 The General Hospital Corporation Miniature swine transgenic for one or more coagulation factors
EP3799893A1 (en) 2013-11-04 2021-04-07 LifeCell Corporation Methods of removing alpha-galactose
CN104677866A (zh) * 2014-03-25 2015-06-03 中国科学院大连化学物理研究所 测定CP装载siRNA体系中siRNA释放的方法
RU2711147C2 (ru) 2014-05-20 2020-01-15 Юниверсити Оф Айова Рисерч Фаундейшн Терапевтические соединения для лечения болезни хантингтона
CN104232670A (zh) * 2014-08-25 2014-12-24 中国水产科学研究院黑龙江水产研究所 一种采用鱼类转基因方法构建的基于鲤鱼mstn干涉载体及其构建方法
EP3314258B1 (en) 2015-06-26 2023-11-15 The Regents of the University of California Antigenic peptides and uses thereof for diagnosing and treating autism
MX2018004263A (es) 2015-10-08 2019-08-16 Harvard College Edición genómica multiplexada.
CN106918697B (zh) * 2017-02-15 2018-07-31 中国医学科学院北京协和医院 一种预测ra药物疗效的诊断标志物及其应用
KR102746223B1 (ko) * 2017-04-20 2024-12-27 이제네시스, 인크. 유전자 변형 동물의 생성 방법
CN107760682B (zh) * 2017-10-18 2020-12-18 云南大学 一种可用于分子防治害虫的核酸序列及其应用
CN110628807B (zh) * 2018-05-30 2021-06-18 中国科学院植物研究所 盐角草SePSS蛋白及其编码基因与应用
WO2020033456A1 (en) * 2018-08-06 2020-02-13 Nemametrix Inc Homologous recombination reporter construct and uses thereof
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
WO2020072982A1 (en) 2018-10-05 2020-04-09 Xenotherapeutics, Inc. Xenotransplantation products and methods
US20210395738A1 (en) 2018-11-08 2021-12-23 Greenlight Biosciences, Inc. Control of insect infestation
CN110055253A (zh) * 2019-04-28 2019-07-26 复旦大学附属金山医院 一种针对人半胱氨酸蛋白酶抑制剂B的siRNA分子及其应用
US20220012673A1 (en) * 2020-07-13 2022-01-13 ZenDesk, Inc. Maintaining status information for customer-support agents across multiple channels
AU2021392972A1 (en) * 2020-12-01 2023-06-08 ETH Zürich Dna constructs comprising alternative promoters
US20240240178A1 (en) * 2021-05-06 2024-07-18 Systems Oncology, Llc Sirna constructs for inhibiting gene expression in targeted cancer cells
US20240271112A1 (en) * 2021-06-01 2024-08-15 University Of Massachusetts Cas9 nickase-mediated gene editing
WO2023004365A1 (en) * 2021-07-20 2023-01-26 Sio Gene Therapies Inc. Vector constructs for delivery of nucleic acids encoding therapeutic proteasome activator complex subunits and methods of using the same
CN115011601B (zh) * 2022-06-27 2023-07-21 山东大学齐鲁医院 一种干扰JUND表达的shRNA、重组腺相关病毒载体及其应用
CN118581151B (zh) * 2024-05-29 2024-12-06 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种猪becn1基因敲除细胞的构建方法及其应用
CN120608104B (zh) * 2025-08-12 2025-11-25 中国科学院水生生物研究所 lasp1基因在鱼类抗病毒免疫调控中的功能和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4517338A (en) 1983-06-20 1985-05-14 Chiron Corporation Multiple reactor system and method for polynucleotide synthesis
US4888274A (en) 1985-09-18 1989-12-19 Yale University RecA nucleoprotein filament and methods
FR2646438B1 (fr) 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AU3276599A (en) * 1998-03-12 1999-09-27 Japan As Represented By Director General Of Agency Of Industrial Science And Technology Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CZ295108B6 (cs) 1998-03-20 2005-05-18 Benitec Australia Ltd Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen
WO2000011187A1 (en) 1998-08-18 2000-03-02 Bio-Transplant, Inc. Molecular sequence of swine retrovirus and methods of use
US20030084471A1 (en) * 2000-03-16 2003-05-01 David Beach Methods and compositions for RNA interference
AU2001245793A1 (en) * 2000-03-16 2001-09-24 Cold Spring Harbor Laboratory Methods and compositions for rna interference
EP1309726B2 (en) 2000-03-30 2018-10-03 Whitehead Institute For Biomedical Research Rna sequence-specific mediators of rna interference
US20030143597A1 (en) * 2000-12-28 2003-07-31 Finney Robert E. Methods for making polynucleotide libraries, polynucleotide arrays, and cell libraries for high-throughput genomics analysis
EP1386004A4 (en) 2001-04-05 2005-02-16 Ribozyme Pharm Inc MODULATION OF GENE EXPRESSION ASSOCIATED WITH INFLAMMATORY PROLIFERATION AND GROWTH OF NEURITIES BY METHODS INVOLVING NUCLEIC ACID
CN1522300A (zh) * 2001-05-01 2004-08-18 独立行政法人产业技术综合研究所 新型大酶
JP4210737B2 (ja) * 2001-07-12 2009-01-21 ユニバーシティー オブ マサチューセッツ 遺伝子サイレンシングを仲介する低分子干渉リボ核酸のインビボにおける製造方法
WO2003012052A2 (en) 2001-07-30 2003-02-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Specific inhibition of gene expression by small double stranded rnas
US7732193B2 (en) 2001-09-13 2010-06-08 California Institute Of Technology Method for expression of small RNA molecules within a cell
US20030148519A1 (en) 2001-11-14 2003-08-07 Engelke David R. Intracellular expression and delivery of siRNAs in mammalian cells
JP2005538685A (ja) 2001-12-21 2005-12-22 トランザイム， インコーポレイテッド レンチウイルスベクターを使用して遺伝的に改変された動物を生成するための方法および組成物
EP1458879A2 (en) 2001-12-21 2004-09-22 Oxford Biomedica (UK) Limited Method for producing a transgenic organism using a lentiviral expression vector such as eiav
GB0130955D0 (en) 2001-12-24 2002-02-13 Cancer Res Ventures Expression system
EP1572902B1 (en) 2002-02-01 2014-06-11 Life Technologies Corporation HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
US20030203868A1 (en) * 2002-02-06 2003-10-30 Bushman Frederic D. Inhibition of pathogen replication by RNA interference
US20040045043A1 (en) 2002-05-20 2004-03-04 Finney Robert E. Compositions and methods for generating conditional knockouts
NZ562736A (en) 2002-08-21 2009-07-31 Revivicor Inc Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
US20040072769A1 (en) * 2002-09-16 2004-04-15 Yin James Qinwei Methods for design and selection of short double-stranded oligonucleotides, and compounds of gene drugs
CN1276976C (zh) * 2003-10-30 2006-09-27 封江南 单一载体编码多个发夹结构小干扰性rna表达系统及其构建方法
EP1582591A3 (en) * 2004-02-27 2005-12-21 Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut Sirna and their use for knock down expression of porcine endogenous retrovirus

Similar Documents

Publication Publication Date Title
JP2007512027A5 (enExample)
CN101939446B (zh) 人类卵巢癌中的微小rna特征
CN101835902B (zh) 编码ncrna的超保守区域
EP2516647B1 (en) Molecule for treating an inflammatory disorder
JP5426383B2 (ja) 慢性リンパ球性白血病におけるｍｉＲ−２９およびｍｉＲ−１８１によって制御されるＴＣＬ１発現
ES2739804T3 (es) Compuestos terapéuticos
US8497364B2 (en) Triggered RNAi
JP2019512014A (ja) がん診断法および治療法におけるｐｉＲＮＡを使用する組成物および方法
JP2002272489A5 (enExample)
EP1838875A2 (en) Compositions and methods for modulating gene expression using self-protected oligonucleotides
US20050164212A1 (en) Modulation of gene expression using DNA-RNA hybrids
EP3957751B1 (en) Short rna-primed xeno sensor module amplification-based short rna detection technique
CN102181517A (zh) 绵羊mstn基因启动子区两个新snp位点检测及其检测方法的建立
Lee et al. Lineage specific evolutionary events on SFTPB gene: Alu recombination-mediated deletion (ARMD), exonization, and alternative splicing events
US11357853B2 (en) Inhibition of a lncRNA for treatment of neuroblastoma
EP4466357A2 (en) Methods of improving health with apolipoprotein e (apoe) inhibitors
AU2015203577A1 (en) Molecule for treating an inflammatory disorder
CN118541481A (zh) 用分化簇109(cd109)抑制剂治疗骨矿物质密度降低的方法
AU2014202073B2 (en) MicroRNA signatures in human ovarian cancer
JPWO2020191141A5 (enExample)
CN1510144A (zh) hfg12凝血酶原酶双链RNA和反义寡核苷酸的构建方法及其应用
WO2010022235A2 (en) Genome-wide association study of autism reveals a comnon novel risk locus at 5p14.1